Skip to main content

Advertisement

Contact Kittiphong Thiboonboon

From: Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand

Contact corresponding author